Takeda Pharmaceutical Company Limited (TAK)
USD 13.11
(-1.87%)
USD 13.11
(-1.87%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 5258.2 Billion JPY | 13.96% |
| 2023 | 3848.81 Billion JPY | 10.1% |
| 2022 | 3495.71 Billion JPY | -4.73% |
| 2021 | 3669.14 Billion JPY | -17.65% |
| 2020 | 4455.69 Billion JPY | -11.75% |
| 2019 | 5048.85 Billion JPY | 630.51% |
| 2018 | 691.14 Billion JPY | -16.27% |
| 2017 | 825.43 Billion JPY | 160.56% |
| 2016 | 316.79 Billion JPY | 310.18% |
| 2015 | 77.23 Billion JPY | -60.18% |
| 2014 | 193.93 Billion JPY | -27.69% |
| 2013 | 268.2 Billion JPY | 147.61% |
| 2012 | 108.31 Billion JPY | 153.78% |
| 2011 | -201.41 Billion JPY | 18.7% |
| 2010 | -247.73 Billion JPY | -18.1% |
| 2009 | -209.76 Billion JPY | 86.95% |
| 2008 | -1607.4 Billion JPY | 1.75% |
| 2007 | -1636.07 Billion JPY | -1.39% |
| 2006 | -1613.65 Billion JPY | -29.52% |
| 2005 | -1245.82 Billion JPY | -17.37% |
| 2004 | -1061.44 Billion JPY | -5.05% |
| 2003 | -1010.4 Billion JPY | -36.29% |
| 2002 | -741.37 Billion JPY | -19.91% |
| 2001 | -618.27 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | 5258.2 Billion JPY | 36.62% |
| 2024 Q4 | 5258.2 Billion JPY | 20.17% |
| 2024 Q3 | 4375.8 Billion JPY | 0.34% |
| 2024 Q1 | 4430.73 Billion JPY | 6.63% |
| 2024 Q2 | 4361.15 Billion JPY | -10.36% |
| 2023 Q3 | 3601.76 Billion JPY | -8.55% |
| 2023 Q2 | 3938.5 Billion JPY | -0.45% |
| 2023 FY | 3848.81 Billion JPY | 10.1% |
| 2023 Q1 | 3956.26 Billion JPY | 13.17% |
| 2023 Q4 | 3848.81 Billion JPY | 6.86% |
| 2022 Q3 | 3630.53 Billion JPY | 0.19% |
| 2022 Q1 | 3750.94 Billion JPY | 2.23% |
| 2022 Q2 | 3623.47 Billion JPY | -3.4% |
| 2022 FY | 3495.71 Billion JPY | -4.73% |
| 2022 Q4 | 3495.71 Billion JPY | -3.71% |
| 2021 Q1 | 4485.17 Billion JPY | 0.66% |
| 2021 FY | 3669.14 Billion JPY | -17.65% |
| 2021 Q2 | 4277.16 Billion JPY | -4.64% |
| 2021 Q4 | 3669.14 Billion JPY | -11.23% |
| 2021 Q3 | 4133.41 Billion JPY | -3.36% |
| 2020 Q2 | 4481.09 Billion JPY | -11.42% |
| 2020 Q1 | 5058.9 Billion JPY | 0.2% |
| 2020 Q3 | 4653.47 Billion JPY | 3.85% |
| 2020 Q4 | 4455.69 Billion JPY | -4.25% |
| 2020 FY | 4455.69 Billion JPY | -11.75% |
| 2019 Q4 | 5048.85 Billion JPY | 124.3% |
| 2019 Q2 | 683.45 Billion JPY | -10.48% |
| 2019 Q1 | 763.49 Billion JPY | 10.47% |
| 2019 FY | 5048.85 Billion JPY | 630.51% |
| 2019 Q3 | 2250.91 Billion JPY | 229.34% |
| 2018 Q4 | 691.14 Billion JPY | -1.01% |
| 2018 FY | 691.14 Billion JPY | -16.27% |
| 2018 Q3 | 698.21 Billion JPY | -1.17% |
| 2018 Q2 | 706.46 Billion JPY | -0.85% |
| 2018 Q1 | 712.54 Billion JPY | -13.68% |
| 2017 Q4 | 825.43 Billion JPY | 98.07% |
| 2017 Q3 | 416.73 Billion JPY | 25.48% |
| 2017 Q1 | 372.73 Billion JPY | 17.66% |
| 2017 Q2 | 332.12 Billion JPY | -10.9% |
| 2017 FY | 825.43 Billion JPY | 160.56% |
| 2016 Q2 | 120.75 Billion JPY | -22.97% |
| 2016 Q4 | 316.79 Billion JPY | 87.27% |
| 2016 FY | 316.79 Billion JPY | 310.18% |
| 2016 Q3 | 169.16 Billion JPY | 40.1% |
| 2016 Q1 | 156.75 Billion JPY | 102.96% |
| 2015 Q3 | 131.36 Billion JPY | -33.89% |
| 2015 Q1 | 233 Billion JPY | 20.14% |
| 2015 Q4 | 77.23 Billion JPY | -41.21% |
| 2015 Q2 | 198.7 Billion JPY | -14.72% |
| 2015 FY | 77.23 Billion JPY | -60.18% |
| 2014 Q4 | 193.93 Billion JPY | -44.62% |
| 2014 FY | 193.93 Billion JPY | -27.69% |
| 2014 Q3 | 350.17 Billion JPY | -20.2% |
| 2014 Q2 | 438.83 Billion JPY | 59.71% |
| 2014 Q1 | 274.76 Billion JPY | 2.45% |
| 2013 Q4 | 268.2 Billion JPY | -4.09% |
| 2013 FY | 268.2 Billion JPY | 147.61% |
| 2013 Q1 | 337.41 Billion JPY | 211.51% |
| 2013 Q2 | 329.26 Billion JPY | -2.41% |
| 2013 Q3 | 279.63 Billion JPY | -15.07% |
| 2012 Q3 | 348.57 Billion JPY | 7.99% |
| 2012 Q4 | 108.31 Billion JPY | -68.93% |
| 2012 FY | 108.31 Billion JPY | 153.78% |
| 2012 Q1 | -189.99 Billion JPY | 5.67% |
| 2012 Q2 | 322.78 Billion JPY | 269.89% |
| 2011 Q2 | -218.99 Billion JPY | 3.4% |
| 2011 Q3 | -190.04 Billion JPY | 13.22% |
| 2011 Q4 | -201.41 Billion JPY | -5.98% |
| 2011 FY | -201.41 Billion JPY | 18.7% |
| 2011 Q1 | -226.7 Billion JPY | 8.49% |
| 2010 Q4 | -247.73 Billion JPY | 8.87% |
| 2010 Q3 | -271.85 Billion JPY | -5.52% |
| 2010 Q2 | -257.62 Billion JPY | 0.0% |
| 2010 FY | -247.73 Billion JPY | -18.1% |
| 2009 FY | -209.76 Billion JPY | 86.95% |
| 2009 Q4 | -209.76 Billion JPY | 4.16% |
| 2009 Q3 | -218.86 Billion JPY | 0.0% |
| 2008 FY | -1607.4 Billion JPY | 1.75% |
| 2007 FY | -1636.07 Billion JPY | -1.39% |
| 2006 FY | -1613.65 Billion JPY | -29.52% |
| 2005 FY | -1245.82 Billion JPY | -17.37% |
| 2004 FY | -1061.44 Billion JPY | -5.05% |
| 2003 FY | -1010.4 Billion JPY | -36.29% |
| 2002 FY | -741.37 Billion JPY | -19.91% |
| 2001 FY | -618.27 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.65 Billion USD | -197652.485% |
| Bausch Health Companies Inc. | 21.44 Billion USD | -24424.047% |
| Catalent, Inc. | 4.69 Billion USD | -111800.426% |
| Emergent BioSolutions Inc. | 765.8 Million USD | -686528.493% |
| Elanco Animal Health Incorporated | 5.42 Billion USD | -96878.993% |
| Perrigo Company plc | 3.32 Billion USD | -158179.432% |
| Teva Pharmaceutical Industries Limited | 16.92 Billion USD | -30963.987% |
| Zoetis Inc. | 4.76 Billion USD | -110320.013% |